Crossref
Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms
BMJ · 27.10.2026 · 395 · e101252
DOI: 10.1136/bmj-2026-101252 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, online erschienen am 27.10.2026. Verfasst von Sophie Borland. Beteiligte Einrichtung: Hertfordshire. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hertfordshire.
Zitieren
APA
Borland, S. (2026). Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms. BMJ, 395, e101252. https://doi.org/10.1136/bmj-2026-101252
Vancouver
Borland S. Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms. BMJ. 2026;395:e101252. doi:10.1136/bmj-2026-101252
BibTeX
@article{Borland2026,
author = {Borland, Sophie},
title = {Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e101252},
doi = {10.1136/bmj-2026-101252}
}
EUVIMED